Search Results - "Maykut, R.J"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Two Year Follow-Up of Patients with Chronic Autoimmune Urticaria Treated with Omalizumab by Kaplan, A.P, Joseph, K, Murphy, T, Ramey, J, Maykut, R.J, Zeldin, R.K

    Published in Journal of allergy and clinical immunology (01-02-2010)
    “…In our proof of concept study, after 4 months of omalizumab therapy for chronic autoimmune urticaria, seven patients responded completely, four improved but…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Treatment of Chronic Autoimmune Urticaria with Omalizumab by Kaplan, A.P, Joseph, K, Maykut, R.J, Zeldin, R.K

    Published in Journal of allergy and clinical immunology (01-02-2008)
    “…Rationale Approximately 40% of patients with chronic urticaria have an IgG antibody directed to the α-subunit of the high affinity IgE receptor (chronic…”
    Get full text
    Journal Article
  4. 4

    Addition of Omalizumab Reduces School Absenteeism in Children with Moderate-Severe Persistent Asthma by Milgrom, H, Massanari, M, Maykut, R.J, Kianifard, F, Zeldin, R.K, Geba, G.P

    “…The subgroup of school-aged children (OMA, n = 275; PBO, n = 156) had a mean age of 10.5 y, mean serum IgE level of 332.6 IU/mL, mean baseline inhaled…”
    Get full text
    Journal Article
  5. 5

    Effect of Omalizumab on Measures of Control in Adolescents with Moderate-Severe Persistent Asthma by Pollard, S.J, Maykut, R.J, Massanari, M, Kianifard, F, Zeldin, R.K, Geba, G.P

    “…Data were pooled from 5 randomized, double-blind, placebo (PBO)-controlled trials in patients with moderate-severe persistent IgE-mediated asthma that included…”
    Get full text
    Journal Article
  6. 6

    Adding Omalizumab to the Therapy of Adolescents With Persistent Uncontrolled Moderate—Severe Allergic Asthma by Massanari, M., Milgrom, H., Pollard, S., Maykut, R.J., Kianifard, Farid, Fowler-Taylor, A., Geba, G.P., Zeldin, R.K.

    Published in Clinical pediatrics (01-10-2009)
    “…Objective. This study aimed to evaluate the effectiveness of omalizumab among adolescents with moderate—severe allergic asthma inadequately controlled with…”
    Get full text
    Journal Article